Literature DB >> 16147652

Microwave endometrial ablation for menorrhagia: outcome at 2 years--experience of a district general hospital.

B Sharma1, J Preston, C Ray.   

Abstract

One hundred and twenty-three women underwent microwave endometrial ablation (MEA) for the treatment of dysfunctional uterine bleeding (DUB). The mean age at treatment was 40.2 years and the average treatment time was 2 minutes 50 seconds. All patients stayed as day cases, except for two who stayed overnight, one due to pain and the other due to urinary retention. The follow-up was carried out at 6 months, 1 and 2 years, respectively. The success rate was 80%, 76% and 70% at 6 months and 1-year and 2-year follow-up. The patient satisfaction rate was 80%, 75% and 68% at 6 months, 1 year and 2 years, respectively. However, in women 45 years old and over the success rate was more than 90%, suggesting that MEA could be a preferred procedure for treatment of DUB in this age group compared to younger women, especially in those who do not benefit from the mirena intrauterine system or decline it. Approximately 70% of patients, who underwent hysterectomy due to the failure of treatment, had uterine/pelvic pathology in the form of adenomyosis, fibroid uterus or endometriosis; therefore prior to MEA, proper patient selection is vital. There were a few minor complications but no uterine perforation or emergency hysterectomies in the group studied.

Entities:  

Mesh:

Year:  2004        PMID: 16147652     DOI: 10.1080/01443610400019005

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  5 in total

Review 1.  Microwave tissue ablation: biophysics, technology, and applications.

Authors:  Christopher L Brace
Journal:  Crit Rev Biomed Eng       Date:  2010

2.  Does the working temperature affect the outcome following microwave endometrial ablation?

Authors:  M Harmon; A V Kasbekar; A Sinha; V Andrews
Journal:  Ir J Med Sci       Date:  2016-06-30       Impact factor: 1.568

3.  Effect of a hormone-releasing intrauterine system (Mirena(®)) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection.

Authors:  Hugo Maia; Clarice Haddad; Julio Casoy; Rebeca Maia; Nathanael Pinheiro; Elsimar M Coutinho
Journal:  Int J Womens Health       Date:  2012-04-12

Review 4.  The complementary and alternative medicine for endometriosis: a review of utilization and mechanism.

Authors:  Sai Kong; Yue-Hui Zhang; Chen-Fang Liu; Ilene Tsui; Ying Guo; Bei-Bei Ai; Feng-Juan Han
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-19       Impact factor: 2.629

5.  Long-term outcome of endometrial ablation therapy with Cavaterm Thermal Balloon in patients with abnormal uterine bleeding

Authors:  Mojgan Karimi-Zarchi; Marzieh Fathi; Afsar Tabatabaie; Farimah Shamsi; Leila Allahqoli; Leila Zanbagh; Seyed Mohammad Amin Hashemipour; Liselotte Mettler
Journal:  J Turk Ger Gynecol Assoc       Date:  2019-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.